Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
EnteroGuard oral powder
091101000BBUFA0
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Entrocalm Replace granules 4.87g sachets
0902012H0BSAAA0
|
Entrocalm (Oral Rehydration) | Oral rehydration salts | Nutrition and Blood | No data available |
|
Ephynal 100mg chewable tablets
0906050T0BBAIAP
|
Ephynal | Tocopheryl acetate | Nutrition and Blood | No data available |
|
Ephynal 200mg tablets
0906050T0BBADAD
|
Ephynal | Tocopheryl acetate | Nutrition and Blood | No data available |
|
Ephynal 50mg tablets
0906050T0BBACAC
|
Ephynal | Tocopheryl acetate | Nutrition and Blood | No data available |
|
Epoetin alfa 2,000units/1ml inj pre-filled syringes
0901030D0AAAWAW
|
Epoetin alfa | Epoetin alfa | Nutrition and Blood | No data available |
|
Epoetin alfa 40,000units/1ml solution for injection vials
0901030D0AAASAS
|
Epoetin alfa | Epoetin alfa | Nutrition and Blood | No data available |
|
Epoetin alfa 7,000units/0.7ml inj pre-filled syringes
0901030D0AAAPAP
|
Epoetin alfa | Epoetin alfa | Nutrition and Blood | No data available |
|
Epoetin alfa 9,000units/0.9ml inj pre-filled syringes
0901030D0AAARAR
|
Epoetin alfa | Epoetin alfa | Nutrition and Blood | No data available |
|
Epoetin beta 1,000units/0.3ml inj pre-filled syringes
0901030E0AAAPAP
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin beta 10,000unit inj pre-filled disposable devices
0901030E0AAAIAI
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin beta 100,000unit inj vials
0901030E0AAAMAM
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin beta 20,000unit inj pre-filled disposable devices
0901030E0AAAJAJ
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin beta 50,000unit inj vials
0901030E0AAAKAK
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin beta 60,000unit inj pre-filled disposable devices
0901030E0AAAWAW
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin delta 1,000units/0.5ml inj pre-filled syringes
0901030L0AAAAAA
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 10,000units/0.5ml inj pre-filled syringes
0901030L0AAAHAH
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 2,000units/0.5ml inj pre-filled syringes
0901030L0AAABAB
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 3,000units/0.3ml inj pre-filled syringes
0901030L0AAACAC
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 4,000units/0.4ml inj pre-filled syringes
0901030L0AAADAD
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 5,000units/0.5ml inj pre-filled syringes
0901030L0AAAEAE
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 6,000units/0.3ml inj pre-filled syringes
0901030L0AAAFAF
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin delta 8,000units/0.4ml inj pre-filled syringes
0901030L0AAAGAG
|
Epoetin delta | Epoetin delta | Nutrition and Blood | No data available |
|
Epoetin theta 1,000units/0.5ml inj pre-filled syringes
0901030S0AAAAAA
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
|
Epoetin theta 10,000units/1ml inj pre-filled syringes
0901030S0AAAFAF
|
Epoetin theta | Epoetin theta | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.